The evolution of adjunctive antiplatelet therapy in non urgent PCI
An EBAC Accredited Educational Programme supported with an unrestricted educational grant from AstraZeneca.

Session details
  • Chairpersons: Hugo KATUS, Patrick W. SERRUYS
  • Speakers: Patrick W. SERRUYS, Andreas BAUMBACH, Ph. Gabriel STEG, Marco VALGIMIGLI, Hugo KATUS
  • Objectives:
    To learn about evolving evidence in adjunctive antiplatelet therapy
    To appreciate the importance of discharge treatment plans
  • To understand the issues surrounding short versus long-term antiplatelet therapy

This programme was EBAC accredited during the EuroPCR Congress 2014, however no CME credits will be provided for viewing this web-cast.

  • Hugo Katus

    Prof. Katus is Clinical Director of the Department of Cardiology, Angiology and Pneumology, as well as Managing Director of the Medical Clinic, Heidelberg.

  • Patrick W. Serruys

    Patrick W. Serruys, is Professor of Interventional Cardiology at the Interuniversity Cardiological Institute of The Netherlands, and the Erasmus University.